On December 1, 2023, PharmAbcine Inc. closed the transaction. The transaction will include participation from new investors Hpbiolab Inc. for 5,336,179 shares and Seung-hwan Choi for 5,336,180 shares.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,915 KRW | -8.91% |
|
-.--% | -22.27% |
1st Jan change | Capi. | |
---|---|---|
-22.27% | 63.87M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- A208340 Stock
- News PharmAbcine Inc.
- PharmAbcine Inc. announced that it has received KRW 30.000001149 billion in funding from Hpbiolab Inc.